Distinct cell death markers identified in critical care patient survivors diagnosed with sepsis-Reference-Cited by-同舟云学术

Distinct cell death markers identified in critical care patient survivors diagnosed with sepsis

Published:2021-03 Issue: Volume:231 Page:1-10
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Mallarpu Chandra Shekar,Ponnana Meenakshi,Prasad Sudhir,Singarapu Maneendra,Kim Jean,Haririparsa Neda,Bratic Nemanja,Brar Harvinder,Chelluri Lakshmi Kiran,Madiraju Charitha

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Sepsis: a roadmap for future research;Cohen;Lancet Infect. Dis.,2015

2. The third international consensus definitions for Sepsis and septic shock (Sepsis-3);Singer;JAMA,2016

3. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy;Parrillo;Ann. Intern. Med.,1990

4. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012;Dellinger;Intensive Care Med.,2013

5. Diagnosis and management of sepsis;Evans;Clin Med (Lond).,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell death proteins in sepsis: key players and modern therapeutic approaches;Frontiers in Immunology;2024-01-11

2. Current insight on the mechanisms of programmed cell death in sepsis-induced myocardial dysfunction;Frontiers in Cell and Developmental Biology;2023-12-15

3. The pathogenesis and potential therapeutic targets in sepsis;MedComm;2023-11-20

4. RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond;Frontiers in Immunology;2023-04-05

5. A new perspective on the potential application of RIPK1 in the treatment of sepsis;Immunotherapy;2023-01